azathioprine has been researched along with Vasculitis, Retinal in 19 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An immunocompetent, 25-year-old gentleman with bilateral chronic uveitis presented to various uveitis clinics at different points of time with documented typical clinical features of Toxoplasma Chorioretinitis (Headlight in fog appearance), Behcet's Disease (Hypopyon with peripheral retinal vasculitis), and Presumed Ocular Tuberculosis (Granulomatous Intermediate Uveitis with positive Interferon-gamma release assay) and had been treated with anti-toxoplasma drugs, oral prednisolone, and immunomodulation with oral Mycophenolate/oral Azathioprine to no avail." | 3.96 | Isolated intraocular histiocytosis-A rarely reported entity masquerading clinically as uveitis. ( Dudani, AI; Moreker, MR; Patel, K; Sharma, TR; Smruti, BK, 2020) |
| "Ocular lesions, the main morbidity of Behcet's disease (BD), are the most difficult to treat." | 2.75 | Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). ( Akhlaghi, M; Chams-Davatchi, C; Davatchi, F; Faezi, T; Naderi, N; Nadji, A; Rezaipoor, M; Sadeghi-Abdollahi, B; Shahram, F; Shams, H, 2010) |
| "Adamantiades-Behcet's disease (ABD) is a chronic recurrent vasculitis whose aetiology is still unclear." | 2.43 | [Adamantiades-Behcet's disease]. ( Krause, L, 2005) |
| "Retinal vasculitis was noted in majority of affected eyes and specifically arteritis was noticed in 32/57(56%)." | 1.51 | Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population. ( Kunavisarut, P; Pathanapitoon, K; Rothova, A; Saravuttikul, FA, 2019) |
| "Azathioprine was used at 2-3 mg/kg daily." | 1.40 | Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years. ( Akhlaghi, M; Ashofteh, F; Chams-Davatchi, C; Davatchi, F; Faezi, T; Ghodsi, Z; Mohtasham, N; Nadji, A; Sadeghi Abdollahi, B; Shahram, F; Shams, H, 2014) |
| "Even with proper immunosuppressive treatment, SLE can relapse." | 1.37 | Lupus relapse presented as frosted branch retinal angiitis: case report. ( Arellanes-Garcia, L; Cornejo-Ballesteros, H; Hernandez-Da Mota, SE; Melgoza-del-Angel, C; Recillas-Gispert, C; Sanchez-Gonzalez, R; Teran-Estrada, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 12 (63.16) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| B Singh, S | 1 |
| Kanakath, AV | 1 |
| Saravanan, V | 1 |
| K S, J | 1 |
| V, N | 1 |
| Kawali, A | 1 |
| Bavaharan, B | 1 |
| Sanjay, S | 1 |
| Mohan, A | 1 |
| Mahendradas, P | 1 |
| Shetty, B | 1 |
| Moreker, MR | 1 |
| Dudani, AI | 1 |
| Sharma, TR | 1 |
| Patel, K | 1 |
| Smruti, BK | 1 |
| Matsuura, M | 1 |
| Taniguchi, Y | 1 |
| Terada, Y | 1 |
| Mohammadi, M | 1 |
| Shahram, F | 4 |
| Shams, H | 3 |
| Akhlaghi, M | 3 |
| Ashofteh, F | 2 |
| Davatchi, F | 4 |
| Starr, MR | 1 |
| Smith, WM | 1 |
| Postlethwaite, B | 1 |
| Wynn, HG | 1 |
| Pattanaik, D | 1 |
| Ost, S | 1 |
| MacDonald, CB | 1 |
| Walton, RC | 1 |
| Kim, S | 1 |
| Myers, LK | 1 |
| Brown Lobbins, M | 1 |
| Pathanapitoon, K | 1 |
| Kunavisarut, P | 1 |
| Saravuttikul, FA | 1 |
| Rothova, A | 1 |
| Majumder, PD | 1 |
| Sitaula, RK | 1 |
| Biswas, J | 1 |
| Sadeghi Abdollahi, B | 1 |
| Nadji, A | 3 |
| Chams-Davatchi, C | 2 |
| Faezi, T | 2 |
| Ghodsi, Z | 1 |
| Mohtasham, N | 1 |
| Tabbara, KF | 1 |
| Al-Hemidan, AI | 1 |
| Cantoni, N | 1 |
| Meyer, P | 1 |
| Katan, M | 1 |
| Kappos, L | 1 |
| Hess, C | 1 |
| Daikeler, T | 1 |
| Donghi, D | 1 |
| Mainetti, C | 1 |
| Rezaipoor, M | 1 |
| Sadeghi-Abdollahi, B | 1 |
| Naderi, N | 1 |
| Jackson, TE | 1 |
| Pathak, S | 1 |
| Doran, RM | 1 |
| Hernandez-Da Mota, SE | 1 |
| Arellanes-Garcia, L | 1 |
| Recillas-Gispert, C | 1 |
| Cornejo-Ballesteros, H | 1 |
| Melgoza-del-Angel, C | 1 |
| Teran-Estrada, L | 1 |
| Sanchez-Gonzalez, R | 1 |
| Chams, H | 1 |
| Jamshidi, A | 1 |
| Akbarian, M | 1 |
| Gharibdoost, F | 1 |
| Krause, L | 1 |
| Boura, P | 1 |
| Tselios, K | 1 |
| Kamali, S | 1 |
| Skendros, P | 1 |
| Sarantopoulos, A | 1 |
| Topouzis, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Low-dose IL-2 Treatment on Behcet's Disease[NCT04065672] | Phase 2 | 15 participants (Anticipated) | Interventional | 2019-11-12 | Recruiting | ||
| A Double Blind Cross Over Clinical Trial to Determine Colchicine Efficacy in Behcet's Disease[NCT00700297] | Phase 2 | 169 participants (Actual) | Interventional | 2002-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for azathioprine and Vasculitis, Retinal
| Article | Year |
|---|---|
[Adamantiades-Behcet's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Synd | 2005 |
3 trials available for azathioprine and Vasculitis, Retinal
| Article | Year |
|---|---|
High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
Topics: Administration, Intravenous; Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Double-Blind Me | 2017 |
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Behcet Syndrome; Cyclophosp | 2010 |
Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
Topics: Azathioprine; Behcet Syndrome; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combina | 2003 |
15 other studies available for azathioprine and Vasculitis, Retinal
| Article | Year |
|---|---|
A Case of Idiopathic Retinitis Vasculitis Aneurysms and Neuroretinitis (IRVAN) Treated with Adalimumab.
Topics: Adalimumab; Adolescent; Aneurysm; Azathioprine; Chorioretinitis; Female; Fluorescein Angiography; Hu | 2023 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Dru | 2020 |
Isolated intraocular histiocytosis-A rarely reported entity masquerading clinically as uveitis.
Topics: Adult; Azathioprine; Behcet Syndrome; Histiocytosis; Humans; Male; Retinal Vasculitis; Uveitis | 2020 |
Retinal and Choroidal Detachment in Antineutrophil Cytoplasmic Antibody-Associated Scleritis and Retinal Vasculitis Mimicking Choroidal Tumor.
Topics: Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Azathioprine; Choro | 2017 |
A Teenage Girl With Aseptic Meningitis and Unilateral Blurry Vision.
Topics: Adolescent; Azathioprine; Behcet Syndrome; Drug Therapy, Combination; Female; Glucocorticoids; Human | 2017 |
Retinal Vasculitis and Choroidopathy in Pediatric-Onset Mixed Connective Tissue Disease.
Topics: Adolescent; Antibodies, Antinuclear; Azathioprine; Choroid Diseases; Cyclophosphamide; Diagnostic Te | 2017 |
Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Topics: Adolescent; Adult; Age of Onset; Azathioprine; Behcet Syndrome; Child; Drug Therapy, Combination; Fe | 2019 |
Pediatric Eales Disease: An Indian Tertiary Eye Center Experience.
Topics: Adolescent; Antitubercular Agents; Azathioprine; Child; Female; Follow-Up Studies; Glucocorticoids; | 2018 |
Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
Topics: Azathioprine; Behcet Syndrome; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Humans; | 2014 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; | 2008 |
A confusing patient's history: small or large vessel vasculitis?
Topics: Autoantibodies; Azathioprine; Conjunctivitis; Cyclophosphamide; Diagnosis, Differential; Drug Therap | 2010 |
Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement.
Topics: Adolescent; Antibodies, Monoclonal; Arthritis; Aspirin; Azathioprine; Behcet Syndrome; Chronic Disea | 2010 |
Behçet disease presenting with frosted branch angiitis.
Topics: Arthritis; Azathioprine; Behcet Syndrome; Fundus Oculi; Hematocele; HLA-B Antigens; HLA-B51 Antigen; | 2011 |
Lupus relapse presented as frosted branch retinal angiitis: case report.
Topics: Adolescent; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervou | 2011 |
Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD).
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cycl | 2006 |